Solid Biosciences Inc.

US$6.59As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SLDBHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (37.10%)
Div yield —
ROE (76.87%)
Biotechnology
Beta (5Y) 2.63
PE TTM —
TSR TTM 22.26%
Mkt cap US$735.5M
ROIC (46.07%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.66
16.29%
300.31%
Hold 3|7|3|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.12
0.13
0.14
15.38%
17.29%
23.32%
29.10%
Revenue$M
42.64
43.60
42.60
45.12
(2.56%)
0.53%
(0.12%)
3.04%
Peers (US$735.5M)
Cap (US$)
PE
733.7M
—
740.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.386
—
—
EBIT/Intx
1.829
0.476
0.380
Own earn%
(41.73)
46.04
26.22
Sh yield%
44.10
35.28
34.97
Owners
Insiders/Inst%
7.88
85.42
Short interest%
4.96
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
2–8
$1 testx
0.1
Incr. ROIC%
7